Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_assertion description "[Therefore, targeting to the AMPA receptor subunit GluR2 can be considered a practical strategy for stroke therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_assertion evidence source_evidence_literature NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_assertion SIO_000772 16215279 NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_assertion wasDerivedFrom befree-2016 NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_assertion wasGeneratedBy ECO_0000203 NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.
- befree-2016 importedOn "2016-02-19" NP517286.RAnGuLH5XGFgGOte4nPez3SLcmfeBCC0u6AsPe-JU5nbM130_provenance.